Ark Surgical Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$1.1M
- Investors
-
4
Ark Surgical General Information
Description
Developer of a medical device company intended to facilitate the contained removal of large internal organs through a laparoscopic keyhole incision. The company's medical devices reduce the risk of cancerous tissue dispersion during laparoscopic surgery and ensure safe organ removal using a power morcellator without the need for open surgery, enabling surgeons to perform minimally invasive laparoscopic surgery without the risks associated with tissue morcellation.
Contact Information
Website
www.ark-surgical.comCorporate Office
- Wadi El Haj 13
- Nazareth 1603611
- Israel
Corporate Office
- Wadi El Haj 13
- Nazareth 1603611
- Israel
Ark Surgical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 01-Jan-2024 | $1.1M | Completed | Generating Revenue | ||
| 3. Later Stage VC (Series B) | 13-Sep-2022 | Cancelled | Generating Revenue | |||
| 2. Seed Round | 01-Jun-2021 | $2.1M | $2.1M | Completed | Generating Revenue | |
| 1. Seed Round | 01-May-2019 | Completed | Startup |
Ark Surgical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary A1 | ||||||||
| Ordinary A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Ark Surgical Patents
Ark Surgical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4262573-A2 | Laparoscopic tissue containment device | Active | 17-Dec-2020 | ||
| EP-4262573-B1 | Laparoscopic tissue containment device | Active | 17-Dec-2020 | ||
| JP-2023554072-A | Laparoscopic tissue containment device | Active | 17-Dec-2020 | ||
| JP-7801345-B2 | Laparoscopic tissue containment device | Active | 17-Dec-2020 | ||
| US-12611226-B2 | Laparoscopic tissue containment device | Active | 17-Dec-2020 | A61B17/3439 |
Ark Surgical Signals
Ark Surgical Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ministry of Economy and Industry | Government | Minority | ||
| Innovation Authority | Government | Minority | ||
| Intempo Ventures | Venture Capital | Minority | ||
| NGT HealthCare II | Venture Capital | Minority |
Ark Surgical Acquisitions (1)
Ark Surgical’s most recent deal was a Merger/Acquisition with SafeSac. The deal was made on 01-Nov-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| SafeSac | 01-Nov-2018 | Merger/Acquisition | Surgical Devices |
Ark Surgical FAQs
-
When was Ark Surgical founded?
Ark Surgical was founded in 2017.
-
Where is Ark Surgical headquartered?
Ark Surgical is headquartered in Nazareth, Israel.
-
What is the size of Ark Surgical?
Ark Surgical has 10 total employees.
-
What industry is Ark Surgical in?
Ark Surgical’s primary industry is Surgical Devices.
-
Is Ark Surgical a private or public company?
Ark Surgical is a Private company.
-
What is Ark Surgical’s current revenue?
The current revenue for Ark Surgical is .
-
How much funding has Ark Surgical raised over time?
Ark Surgical has raised $3.2M.
-
Who are Ark Surgical’s investors?
Ministry of Economy and Industry, Innovation Authority, Intempo Ventures, and NGT HealthCare II have invested in Ark Surgical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process